NovaBridge Biosciences

NBPReported to SECin USCIK 0001778016Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 19. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 19
Form 4 lines at NovaBridge Biosciences, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Dennis Phillip AndrewChief Medical OfficerOption exercisenothing paid10,302 sharesSep 21, 2026Dennis Phillip AndrewChief Medical Officernothing paidExercise · Sep 21Option exercise10,302Sep 21, 2026
Dennis Phillip AndrewChief Medical OfficerOpen-market sell$5,8288,209 sharesSep 21, 2026Dennis Phillip AndrewChief Medical Officer$5,828Sell · Sep 21Open-market sell8,209Sep 21, 2026
Dennis Phillip AndrewChief Medical OfficerOption exercise—23,695 sharesSep 21, 2026Dennis Phillip AndrewChief Medical Officer—Exercise · Sep 21Option exercise23,695Sep 21, 2026
Cao Sean WuxiongChief Bus. Development OfficerOpen-market sell$79,904107,978 sharesSep 11, 2026Cao Sean WuxiongChief Bus. Development Officer$79,904Sell · Sep 11Open-market sell107,978Sep 11, 2026
Cao Sean WuxiongChief Bus. Development OfficerOption exercisenothing paid45,320 sharesSep 8, 2026Cao Sean WuxiongChief Bus. Development Officernothing paidExercise · Sep 8Option exercise45,320Sep 8, 2026